Mindray – MR – Revised Non-Binding Acquisition Proposal Validates GeoInvesting’s Research
Today, Mindray Medical (NYSE:MR) announced a receipt of a revised non-binding proposal to acquire the company at US$27 per ADS or US$27 per [...]
Today, Mindray Medical (NYSE:MR) announced a receipt of a revised non-binding proposal to acquire the company at US$27 per ADS or US$27 per [...]